November 2024
This Season, Consider Giving the Gift of Sight
All of us at Doheny Eye Institute wish to express our sincere thanks and appreciation for the ongoing support of our generous donors who enable us to continue innovative vision research. We hope you will consider supporting Doheny as part of your year-end giving. In fact, this month, your generosity will go even further: a close friend of Doheny who has been personally affected by age-related macular degeneration (AMD) generously stepped forward with a remarkable matching gift challenge. For every dollar you give now through December 31, they will match – up to $50,000. Please consider making a gift of $25, $35, or more today. Click below to learn more about the many ways Doheny makes it easy to give.
Doheny Ad Campaign Hits Local Airwaves
With the season of thankfulness and giving upon us, Doheny recently rolled out advertising spots on local TV and radio aimed at reminding the community about the important work of Doheny Eye Institute – and the importance of donors in helping us continue our innovative vision research. Throughout the month, keep an eye out on Spectrum News 1 for our TV spot, and listen on KNX for our radio spot.
Recap: Inaugural Doheny Oculomics Symposium
On November 23, Doheny hosted the inaugural Oculomics Symposium, led by Yuhua Zhang, PhD, Principal Investigator at Doheny Eye Institute and Professor of Research Ophthalmology at UCLA’s David Geffen School of Medicine.
Oculomics is the study of how changes in the eye, otherwise known as ophthalmic biomarkers, can act as a window to the health of the whole body. As an expert in adaptive optics high-resolution imaging and retinal hemodynamics, Dr. Zhang and his team at Doheny’s Advanced Ophthalmic Imaging Laboratory are at the forefront of supporting the field of Oculomics.
For this inaugural symposium, Dr. Zhang assembled a distinguished lineup of expert speakers from leading institutions, including Doheny and UCLA Stein Eye Institutes, UCLA Bioengineering, Caltech, and Bascom Palmer Eye Institute. It was an engaging day that aimed to advance vital research by uniting basic and clinical researchers to explore the critical role of ocular biomarkers in revealing systemic diseases.
Chief Scientific Officer Deborah Ferrington, PhD, Co-Authors Paper on Age-Related Macular Degeneration (AMD) Risk Factors
Doheny’s Chief Scientific Officer Deborah Ferrington, PhD, co-authored a paper published in the current issue of Free Radical Biology and Medicine. The paper examined the effect of the Y402H polymorphism of Complement Factor H (CFH, rs1061170) and cigarette smoke, predominant genetic and environmental risk factors associated with age-related macular degeneration (AMD).
Doheny Eye Institute in the News
It’s been a busy few months for Doheny Eye Institute – with exciting scientific updates, along with our onsite presence at the annual American Academy of Ophthalmology (AAO) 2024 Annual Meeting.
As a result, several of Doheny’s stellar scientists and ophthalmologists garnered the attention of media outlets. To help catch you up, we’ve included a snapshot of the recent media attention Doheny has received, including links to read the articles.
HCP Live highlighted the paper SriniVas R. Sadda, MD, co-authored on a new deep-learning computer framework using artificial intelligence (AI), called SLIViT (SLice Integration by Vision Transformer), that can teach itself to analyze and diagnose 3D medical images.
Ophthalmology Times Europe covered Dr. Sadda’s presentation at EURETINA 2024, the annual meeting for the European Society of Retina Specialists.
Coverage of Doheny at AAO ran in Ophthalmology Times and Modern Retina. Additionally, onsite interviews and attendance at Doheny presentations resulted in the following media stories:
- Dr. Sadda was featured in Healio and Modern Retina
- Alexander Fein, MD, was interviewed by Ophthalmology Times
- Victoria L. Tseng, MD, PhD, was highlighted in Ophthalmology Times Europe and Ophthalmology Times
- Brian Francis, MD, was featured in Ophthalmology Times
- Vikas Chopra, MD, was included in Ophthalmology Times and Ophthalmology Times Europe
- Alfredo Sadun, MD, PhD, was interviewed by Ophthalmology Times
The Los Angeles Times recently included three Doheny Eye Center UCLA ophthalmologists in its 2024 list of Orange County Visionaries: Benjamin B. Bert, MD, Hugo Y. Hsu, MD, and Dr. Francis.
The Los Angeles Business Journal named our CEO Marissa Goldberg and Chief Scientific Officer Deborah Ferrington, PhD, to its list of Leaders of Influence: Nonprofit & Philanthropy 2024.
Doheny was also included in a Medscape story highlighting eye care and vision research leaders that oppose the proposal to close the National Eye Institute (NEI) and consolidate it with two other arms of the US National Institutes of Health (NIH).